The Scientist

» oncology

Most Recent

In the middle of the 20th century, the National Cancer Institute began testing plant extracts for chemotherapeutic potential—helping to discover some drugs still in use today.

0 Comments

image: How Cancers Evolve Drug Resistance

How Cancers Evolve Drug Resistance

By | April 1, 2017

Researchers unravel the sophisticated ways cancers evade treatments, including immunotherapies, designed to destroy them.

0 Comments

image: Infographic: Mechanisms of Resistance

Infographic: Mechanisms of Resistance

By | April 1, 2017

Cancers appear to be able to evolve resistance to many of the therapies doctors have tried.

0 Comments

image: Infographic: Targeting Cancer Antigens

Infographic: Targeting Cancer Antigens

By | April 1, 2017

Neoantigens may serve as valuable targets for new immunotherapies.

0 Comments

image: Newly Found White Blood Cell Withstands Chemotherapy

Newly Found White Blood Cell Withstands Chemotherapy

By | January 1, 2017

Vaccine-induced macrophages open a new realm of study into remodeling the immune system to reduce the risk of infections during cancer treatment.

1 Comment

New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.

1 Comment

image: Pfizer to Buy Medivation for $14 Billion

Pfizer to Buy Medivation for $14 Billion

By | August 22, 2016

The pharma giant is purchasing the San Francisco–based cancer drugmaker to boost its oncology portfolio.

0 Comments

image: Renowned Cancer Theorist Dies

Renowned Cancer Theorist Dies

By | July 13, 2016

Alfred Knudson, who formulated the “two-hit” theory on the origins of cancer, has passed away at age 93.

1 Comment

image: New FDA Center Aims to Expedite Cancer Treatment Reviews

New FDA Center Aims to Expedite Cancer Treatment Reviews

By | June 30, 2016

The Oncology Center of Excellence, a product of the White House’s Cancer Moonshot initiative, will bring together oncologists across the US Food and Drug Administration.

0 Comments

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS